BRD4
BRD4 (bromodomain containing 4) is a nuclear, chromosome-associated member of the BET family that acts as a chromatin insulator in the DNA damage response. It is also known as HUNKI, MCAP, CAP, HUNK1 and FSHRG4. Browse Assay Genie's current range of BRD4 research reagents below, or read on for the biology behind the target.
BRD4 acts as a chromatin insulator in the DNA damage response pathway. It inhibits DNA damage response signalling by recruiting the condensin-2 complex to acetylated histones. This leads to remodelling of chromatin structure and insulates the region from the damage response by limiting the spread of histone H2AX (H2A.x) phosphorylation.
The protein encoded by the BRD4 gene belongs to the BET (bromodomain and extra-terminal domain) family and sits within the wider group of bromodomain-containing proteins. It contains two bromodomains, a conserved sequence motif that may be involved in chromatin targeting. In UniProt the protein is localised to the nucleus and to chromosomes. Researchers working with BRD4 antibody, BRD4 ELISA kit or BRD4 protein reagents are typically studying chromatin biology, histone acetylation readout or the DNA damage response.
BRD4 is homologous to the murine protein MCAP (the mouse ortholog is Brd4), which associates with chromosomes during mitosis, and to the human RING3 protein, described as a serine/threonine kinase. The BRD4 gene has been implicated as the chromosome 19 target of the translocation t(15;19)(q13;p13.1), which defines an upper respiratory tract carcinoma in young people. Two alternatively spliced transcript variants have been described. Related family members include BRD2 and BRD3.
BRD4 contains two bromodomains, a conserved motif that may be involved in chromatin targeting, making it a focus for studies of chromatin recognition.
BRD4 acts as a chromatin insulator, recruiting condensin-2 to acetylated histones and limiting the spread of H2AX phosphorylation.
The homologous murine protein MCAP associates with chromosomes during mitosis, so BRD4 is studied in chromosome-associated processes.
BRD4 is the chromosome 19 target of the t(15;19) translocation that defines an upper respiratory tract carcinoma in young people.
BRD4 acts as a chromatin insulator in the DNA damage response pathway. It recruits the condensin-2 complex to acetylated histones, remodelling chromatin and limiting the spread of histone H2AX phosphorylation, which inhibits DNA damage response signalling in the insulated region.
The HGNC full name is bromodomain containing 4, and the protein is called bromodomain-containing protein 4 in UniProt. Aliases include HUNKI, MCAP, CAP, HUNK1 and FSHRG4. NCBI notes two alternatively spliced transcript variants have been described for the BRD4 gene.
BRD4 is homologous to murine MCAP, and the mouse ortholog is Brd4. The gene has been implicated as the chromosome 19 target of translocation t(15;19)(q13;p13.1), which defines an upper respiratory tract carcinoma in young people. Check the datasheet of any product for its validated reactivity.
Other BET and bromodomain-containing proteins involved in chromatin recognition, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O60885; product specifications from Assay Genie datasheets.